Trial intelligence / Profile preview

Comparative study of suction curettage versus standard Botox injection in essential axillary hyperhidrosis

2008-000769-49Phase 4Completed

Sponsor
Ghent University Hospital
Start
May 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of botulinum toxin type A in essential axillary hyperhidrosis (2 arms), sponsored by Ghent University Hospital. Primary endpoints: Efficacy magnitude of treatment, Duration of treatment effect and 2 more. Started May 2008; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

essential axillary hyperhidrosis

Beyond the preview

Go deeper on 2008-000769-49.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-000769-49.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call